Concepedia

Phieng Siliphaivanh

PS

15

Publications

1.3K

Citations

13

H-Index

1999

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

United States Military Academy

Phieng Siliphaivanh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1999–2021

15

Publications

15

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

, , +20

Total Synthesis of Gypsetin, Deoxybrevianamide E, Brevianamide E, and Tryprostatin B:  Novel Constructions of 2,3-Disubstituted Indoles

Jeffrey M. Schkeryantz, Jonathan C. G. Woo, Phieng Siliphaivanh et al. · Journal of the American Chemical Society · 1999 · 182 citations

, , +16

Enantioselective Total Synthesis of (+)-Leucascandrolide A Macrolactone

Michael T. Crimmins, Phieng Siliphaivanh · Organic Letters · 2003 · 68 citations

Design of novel histone deacetylase inhibitors

Phieng Siliphaivanh, Paul E. Harrington, David J. Witter et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 42 citations · Full text

, , +6

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

R.L. Palte, Sebastian E. Schneider, Michael D. Altman et al. · ACS Medicinal Chemistry Letters · 2020 · 38 citations · Full text

Rows per page

1–5 of 15